浏览全部资源
扫码关注微信
TGF-βⅡ型受体小分子抑制剂ITD-1对骨髓基质细胞成骨分化和血管形成的作用
Effects of ITD-1, a small-molecule inhibitor of TGF-β type Ⅱ receptor, on osteogenic differentiation and angiogenesis of bone marrow stromal cells
- 第三军医大学学报 2020年42卷第4期 页码：384-391
- 作者机构：
1.400016 重庆，重庆医科大学:附属第一医院生殖健康与不孕症中心
2.400016 重庆，重庆医科大学:生命科学研究院骨发育与再生实验室
- 作者简介：
[刘宏，E-mail: liu1967123@outlook.com LIU Hong, E-mail: liu1967123@outlook.com
- 基金信息：国家自然科学基金面上项目(81672118)
DOI：10.16016/j.1000-5404.201909097
中图分类号： R322.71; R329.28; R977.6收稿：2019-09-12，
修回：2019-12-01，
纸质出版：2020-02-28
- 稿件说明：
移动端阅览
曾继涛, 涂小林, 刘宏. TGF-βⅡ型受体小分子抑制剂ITD-1对骨髓基质细胞成骨分化和血管形成的作用[J]. 第三军医大学学报, 2020,42(4):384-391.
Jitao ZENG, Xiaolin TU, Hong LIU. Effects of ITD-1, a small-molecule inhibitor of TGF-β type Ⅱ receptor, on osteogenic differentiation and angiogenesis of bone marrow stromal cells[J]. Journal of Third Military Medical University, 2020, 42(4): 384-391.
曾继涛, 涂小林, 刘宏. TGF-βⅡ型受体小分子抑制剂ITD-1对骨髓基质细胞成骨分化和血管形成的作用[J]. 第三军医大学学报, 2020,42(4):384-391. DOI： 10.16016/j.1000-5404.201909097.
Jitao ZENG, Xiaolin TU, Hong LIU. Effects of ITD-1, a small-molecule inhibitor of TGF-β type Ⅱ receptor, on osteogenic differentiation and angiogenesis of bone marrow stromal cells[J]. Journal of Third Military Medical University, 2020, 42(4): 384-391. DOI： 10.16016/j.1000-5404.201909097.
摘要
目的
2
探讨TGF-βⅡ型受体(transforming growth factor beta receptor Ⅱ，TGFBR2)的小分子抑制剂ITD-1对小鼠骨髓基质细胞(bone marrow stromal cells，BMSCs)成骨分化和血管形成的影响。
方法
2
将C57/BL6小鼠BMSCs分为3组:不经药物处理为空白组；1‰DMSO处理为DMSO组；10 μmol/L ITD-1处理为ITD-1组。采用CCK-8检测细胞增殖变化；流式细胞仪检测凋亡细胞比例；实时荧光定量PCR(qPCR)测定成骨标志物碱性磷酸酶(ALP)、ostrix(OSX)、Ⅰ型胶原(collagen1
COL1)和骨钙蛋白(osteocalcin
OCN)及成血管相关标志物血管内皮生长因子(vascular endothelial growth factor
VEGF)、血管生成素1(angiopoietin1
ANGPT1) mRNA的表达；碱性磷酸酶染色检测ALP表达情况；茜素红染色检测成骨晚期矿化水平；免疫荧光染色检测成骨标志物OPN及成血管标志物VEGF的表达；小鼠组织培养实验检测体外培养小鼠肱骨骨密度。
结果
2
碱性磷酸酶染色显示ITD-1组染色变浅，茜素红染色结果提示ITD-1组钙盐结节显著减少；与DMSO组比较，ITD-1组BMSCs增殖水平显著降低；流式细胞仪检测显示10 μmol/L的ITD-1不导致细胞凋亡；与DMSO组比较，ITD-1组成骨标志物ALP、OSX、COL1及OCN的mRNA相对表达量均显著降低(
P
<
0.01)，但成血管标志物VEGF和ANGPT1的mRNA相对表达量显著升高(
P
<
0.05)，OPN表达降低而VEGF表达升高(
P
<
0.05)，肱骨骨密度也显著降低(
P
<
0.05)。
结论
2
TGFBR2的小分子抑制剂ITD-1可抑制骨髓基质细胞增殖，在不影响细胞凋亡的情况下对成骨分化具有显著抑制作用，但显著增强血管形成。
Abstract
Objective
2
To investigate the effects of ITD-1
a small-molecule inhibitor of transforming growth factor-β (TGF-β) type Ⅱ receptor (TGFBR2)
on osteogenic differentiation and angiogenesis of bone marrow stromal cells (BMSCs).
Methods
2
BMSCs from C57/BL6 mice were treated with 10 μmol/L ITD-1 or 0.1% DMSO
and the changes in the cell proliferation and apoptosis were examined using cell counting kit-8 (CCK-8) and flow cytometry
respectively. Real-time quantitative PCR (qPCR) was performed to detect the mRNA expression of the osteogenic markers including alkaline phosphatase (ALP)
ostrix (OSX)
collagen type Ⅰ (COL1) and osteocalcin (OCN) and the angiogenesis-related markers including vascular endothelial growth factor (VEGF) and angiopoietin 1 (ANGPT1). ALP staining and alizarin red staining were used to assess the activity of ALP and matrix mineralization in the cells
respectively; immunofluorescence assay was used to detect the expression of the osteogenic marker OPN and the angiogenic marker VEGF. Mouse tissue culture experiment was conducted to test the bone mineral density of mouse humerus cultured in the presence of ITD-1.
Results
2
The intensity of ALP staining was obviously lowered in ITD-1-treated mouse BMSCs as compared with DMSO-treated cells. Alizarin red staining revealed significantly reduced matrix mineralization in ITD-1-treated BMSCs. Treatment with 10 μmol/L ITD-1 for 12 h significantly suppressed the proliferation of the BMSCs but did not cause obvious cell apoptosis. Treatment with ITD-1 significantly decreased the mRNA expression of the osteogenic markers ALP
OSX
COL1 and OCN (
P
<
0.05) but increased the mRNA expression of the angiogenesis-related markers VEGF and ANGPT1 (
P
<
0.05). Immunofluorescence assay also confirmed the decrease of OPN and increase of VEGF expression. The tissue culture experiment showed that culture in the presence of ITD-1 significantly reduced bone mineral density of mouse humerus.
Conclusion
2
ITD-1 inhibits the proliferation and osteogenic differentiation and enhances angiogenesis of mouse BMSCs without affecting cell apoptosis.
关键词
Keywords
references
MAJIDINIA M, SADEGHPOUR A, YOUSEFI B. The roles of signaling pathways in bone repair and regeneration[J]. J Cell Physiol, 2018, 233(4): 2937-2948. DOI: 10.1002/jcp.26042.
LIU Z P, YUAN X, FERNANDES G, et al . The combination of nano-calcium sulfate/platelet rich plasma gel scaffold with BMP2 gene-modified mesenchymal stem cells promotes bone regeneration in rat critical-sizedcalvarial defects[J ] . Stem Cell Res Ther, 2017, 8(1): 122. DOI: 10.1186/s13287-017-0574-6.
POLYMERI A, GIANNOBILE W V, KAIGLER D. Bone marrow stromal stem cells in tissue engineering and regenerative medicine[J]. Horm Et Metab, 2016, 48(11): 700-713. DOI: 10.1055/s-0042-118458.
CHU W X, GAN Y K, ZHUANG Y F, et al . Mesenchymal stem cells and porous β-tricalcium phosphate composites prepared through stem cell screen-enrich-combine(-biomaterials) circulating system for the repair of critical size bone defects in goat tibia[J ] . Stem Cell Res Ther, 2018, 9(1): 157. DOI: 10.1186/s13287-018-0906-1.
KUSUMBE A P, RAMASAMY S K, ADAMS R H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone[J]. Nature, 2014, 507(7492): 323-328. DOI: 10.1038/nature13145.
FELBER K, ELKS P M, LECCA M, et al . Expression ofosterix is regulated by FGF and wnt/β-catenin signalling during osteoblast differentiation[J ] . PLoS ONE, 2015, 10(12): e0144982. DOI: 10.1371/journal.pone.0144982.
SHANG W K, ADZIKA G K, LI Y J, et al . Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma[J ] . Cancer Med, 2019, 8(15): 6684-6699. DOI: 10.1002/cam4.2553.
MAJIDINIA M, SADEGHPOUR A, YOUSEFI B. The roles of signaling pathways in bone repair and regeneration[J]. J Cell Physiol, 2018, 233(4): 2937-2948. DOI: 10.1002/jcp.26042.
ZHANG Y G. Non-smad signaling pathways of the TGF-β family[J]. Cold Spring Harb Perspect Biol, 2017, 9(2): a022129. DOI: 10.1101/cshperspect.a022129.
PETERS S B, WANG Y, SERRA R.TGFBR2 is required in osterix expressing cells for postnatal skeletal development[J]. Bone, 2017, 97: 54-64. DOI: 10.1016/j.bone.2016.12.017.
EHNERT S, HEUBERGER E, LINNEMANN C, et al . TGF-β1-dependent downregulation of HDAC9 inhibits maturation of human osteoblasts[J ] . J Funct Morphol Kinesiol, 2017, 2(4): 41. DOI: 10.3390/jfmk2040041.
BATLLE R, ANDRÉS E, GONZALEZ L, et al . Regulation of tumor angiogenesis and mesenchymal-endothelial transition by p38α through TGF-β and JNK signaling[J ] . Nat Commun, 2019, 10(1): 3071. DOI: 10.1038/s41467-019-10946-y.
WILLEMS E, CABRAL-TEIXEIRA J, SCHADE D, et al . Small molecule-mediated TGF-β type Ⅱ receptor degradation promotescardiomyogenesis in embryonic stem cells[J ] . Cell Stem Cell, 2012, 11(2): 242-252. DOI: 10.1016/j.stem.2012.04.025.
SIDDIQUI J A, PARTRIDGE N C. Physiological bone remodeling: systemic regulation and growth factor involvement[J]. Physiology (Bethesda), 2016, 31(3): 233-245. DOI: 10.1152/physiol.00061.2014.
WU M R, CHEN G Q, LI Y P. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease[J]. Bone Res, 2016, 4: 16009. DOI: 10.1038/boneres.2016.9.
DOLE N S, MAZUR C M, ACEVEDO C, et al . Osteocyte-intrinsic TGF-β signaling regulates bone quality throughperilacunar/canalicular remodeling[J ] . Cell Rep, 2017, 21(9): 2585-2596. DOI: 10.1016/j.celrep.2017.10.115.
HUANG B, WANG W H, LI Q C, et al . Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone[J ] . Nat Commun, 2016, 7: 13885. DOI: 10.1038/ncomms13885.
NIEDŹWIEDZKI T, FILIPOWSKA J. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system[J]. J Mol Endocrinol, 2015, 55(2): R23-R36. DOI: 10.1530/JME-15-0067.
FILIPOWSKA J, TOMASZEWSKI K A, NIEDŹWIEDZKI Ł, et al . The role of vasculature in bone development, regeneration and proper syst emic functioning[J ] . Angiogenesis, 2017, 20(3): 291-302. DOI: 10.1007/s10456-017-9541-1.
KUMAR P, NAUMANN U, AIGNER L, et al . Impaired TGF-β induced growth inhibition contributes to the increased proliferation rate of neural stem cells harboring mutant p53[J ] . Am J Cancer Res, 2015, 5(11): 3436-3445.
0
浏览量
0
下载量
0
CSCD
- 网络PDF下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
